Click on headlines below to download research

The rise of the exosome
ReNeuron Group | 22/05/2018

ReNeuron introduced its exosome nanomedicine programme at its recent capital markets day. While being a preclinical programme, it has three significant…

Playing to its strengths
Be Heard Group | 22/05/2018

Be Heard is building a group of digital marketing specialists, with five partner companies increasingly working together in a process that should become…

Phase IIa trial in Alzheimer’s disease initiated
Oryzon Genomics | 22/05/2018

According to the latest news from Oryzon, the first Alzheimer’s disease (AD) patients (3/90) were recruited into the Phase IIa ETHERAL clinical trial…

Executive interview - Be Heard Group
Executive interview - Be Heard Group | 22/05/2018

Peter Scott, chief executive, and Simon Pyper, the newly installed CFO, talk through Be Heard’s business model and how it is differentiated from…

Banking on HomeSend
eServGlobal | 22/05/2018

eServGlobal enters FY18 with a reduced cost base and a fully funded balance sheet; we are forecasting the core business to be close to EBITDA break-even…